{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T05:11:20Z","timestamp":1794028280958,"version":"4.8.0"},"reference-count":112,"publisher":"Informa UK Limited","issue":"5","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Investigational Drugs"],"published-print":{"date-parts":[[2024,5,3]]},"DOI":"10.1080\/13543784.2024.2343056","type":"journal-article","created":{"date-parts":[[2024,4,23]],"date-time":"2024-04-23T04:09:06Z","timestamp":1713845346000},"page":"509-522","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":6,"title":["Investigational drugs for the treatment of acromegaly: new agents to transform therapy"],"prefix":"10.1080","volume":"33","author":[{"given":"Rosa","family":"Pirchio","sequence":"first","affiliation":[{"name":"Dipartimento di Medicina Clinica e Chirurgia, Sezione di Endocrinologia, Diabetologia, Andrologia e Nutrizione, Universit\u00e0 Federico II di Napoli, Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata S.","family":"Auriemma","sequence":"additional","affiliation":[{"name":"Dipartimento di Medicina Clinica e Chirurgia, Sezione di Endocrinologia, Diabetologia, Andrologia e Nutrizione, Universit\u00e0 Federico II di Napoli, Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Vergura","sequence":"additional","affiliation":[{"name":"Dipartimento di Medicina Clinica e Chirurgia, Sezione di Endocrinologia, Diabetologia, Andrologia e Nutrizione, Universit\u00e0 Federico II di Napoli, Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosario","family":"Pivonello","sequence":"additional","affiliation":[{"name":"Dipartimento di Medicina Clinica e Chirurgia, Sezione di Endocrinologia, Diabetologia, Andrologia e Nutrizione, Universit\u00e0 Federico II di Napoli, Naples, Italy"},{"name":"UNESCO Chair for Health Education and Sustainable Development, Federico II University, Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4049-2559","authenticated-orcid":false,"given":"Annamaria","family":"Colao","sequence":"additional","affiliation":[{"name":"Dipartimento di Medicina Clinica e Chirurgia, Sezione di Endocrinologia, Diabetologia, Andrologia e Nutrizione, Universit\u00e0 Federico II di Napoli, Naples, Italy"},{"name":"UNESCO Chair for Health Education and Sustainable Development, Federico II University, Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2024,4,30]]},"reference":[{"key":"e_1_3_4_2_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-019-0071-6"},{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-13-1022"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11154-020-09588-z"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1530\/EC-22-0349"},{"key":"e_1_3_4_6_1","first-page":"lvae003","article-title":"Efficacy of cabergoline in non-irradiated patients with acromegaly: a multi-centre cohort study","volume":"17","author":"Urwyler SA","year":"2024","unstructured":"Urwyler SA, Samperi I, Lithgow K, et al. Efficacy of cabergoline in non-irradiated patients with acromegaly: a multi-centre cohort study. Eur J Endocrinol. 2024 Jan;17:lvae003.","journal-title":"Eur J Endocrinol"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2014.21"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-017-0791-0"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-015-0677-y"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1210\/er.2010-0002"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2019.02.001"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-2480"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(14)70169-X"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-018-1729-7"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-022-01980-7"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.20945\/2359-3997000000481"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa664"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.EJ19-0266"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.20945\/2359-3997000000160"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.5603\/EP.a2019.0023"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-018-1690-5"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-016-0595-5"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.endonu.2016.05.010"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.15386\/cjmed-435"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0034-1389987"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-012-0382-z"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.EJ12-0272"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-2603"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.1159\/000317314"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1159\/000218323"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2005.02329.x"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.1530\/eje.1.01888"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2004.02082.x"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-021-02711-3"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-020-02501-3"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12902-020-0545-2"},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2019-00825"},{"key":"e_1_3_4_38_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2018-02281"},{"key":"e_1_3_4_39_1","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-17-0996"},{"key":"e_1_3_4_40_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2017-02017"},{"key":"e_1_3_4_41_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-016-0995-5"},{"key":"e_1_3_4_42_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-2032"},{"key":"e_1_3_4_43_1","doi-asserted-by":"publisher","DOI":"10.1186\/1756-9966-32-40"},{"key":"e_1_3_4_44_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-010-0289-5"},{"key":"e_1_3_4_45_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-0654"},{"key":"e_1_3_4_46_1","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-10-0867"},{"key":"e_1_3_4_47_1","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-08-0843"},{"issue":"4","key":"e_1_3_4_48_1","first-page":"571","article-title":"Additional metabolic effects of adding GH receptor antagonist to long-acting somatostatin analog in patients with active acromegaly","volume":"29","author":"Jawiarczyk A","year":"2008","unstructured":"Jawiarczyk A, Ka\u0142uzny M, Bolanowski M, et al. Additional metabolic effects of adding GH receptor antagonist to long-acting somatostatin analog in patients with active acromegaly. Neuro Endocrinol Lett. 2008 Aug;29(4):571\u2013576.","journal-title":"Neuro Endocrinol Lett"},{"key":"e_1_3_4_49_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-007-0037-7"},{"key":"e_1_3_4_50_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-2700"},{"key":"e_1_3_4_51_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-017-0797-7"},{"key":"e_1_3_4_52_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-019-01138-y"},{"key":"e_1_3_4_53_1","doi-asserted-by":"publisher","DOI":"10.1210\/er.2018-00115"},{"key":"e_1_3_4_54_1","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-22-0263"},{"key":"e_1_3_4_55_1","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa526"},{"key":"e_1_3_4_56_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-1179"},{"key":"e_1_3_4_57_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-4113"},{"key":"e_1_3_4_58_1","doi-asserted-by":"publisher","DOI":"10.1530\/endoabs.81.OC4.3"},{"key":"e_1_3_4_59_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-020-01091-7"},{"key":"e_1_3_4_60_1","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-14-0844"},{"key":"e_1_3_4_61_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-012-0460-2"},{"key":"e_1_3_4_62_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-022-02360-6"},{"key":"e_1_3_4_63_1","doi-asserted-by":"publisher","DOI":"10.1517\/14740338.2015.1059817"},{"key":"e_1_3_4_64_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-021-01193-w"},{"key":"e_1_3_4_65_1","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-16-0623"},{"key":"e_1_3_4_66_1","doi-asserted-by":"publisher","DOI":"10.1021\/acsmedchemlett.2c00431"},{"key":"e_1_3_4_67_1","doi-asserted-by":"publisher","DOI":"10.1530\/endoabs.70.AEP627"},{"key":"e_1_3_4_68_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-021-01201-z"},{"key":"e_1_3_4_69_1","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgac643"},{"key":"e_1_3_4_70_1","unstructured":"[cited 2024 Feb 29]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT03792555?term=acrobat%20evolve&rank=1"},{"key":"e_1_3_4_71_1","unstructured":"[cited 2024 Feb 29]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT04261712?term=acrobat%20advance&rank=1"},{"key":"e_1_3_4_72_1","doi-asserted-by":"publisher","DOI":"10.1530\/endoabs.77.P80"},{"key":"e_1_3_4_73_1","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvad114.1083"},{"key":"e_1_3_4_74_1","article-title":"Pharmacokinetics and safety of an improved oral formulation of paltusotine, a selective, non-peptide somatostatin receptor 2 (SST2) agonist for the treatment of acromegaly","volume":"2021","author":"Lou R","year":"2021","unstructured":"Lou R, Burke G, Mui C, et al. Pharmacokinetics and safety of an improved oral formulation of paltusotine, a selective, non-peptide somatostatin receptor 2 (SST2) agonist for the treatment of acromegaly. Endocrine Society. 2021 Mar 20;2021.","journal-title":"Endocrine Society"},{"key":"e_1_3_4_75_1","unstructured":"Available from: https:\/\/clinicaltrials.gov\/study\/NCT04837040?cond=acromegaly&term=paltusotine&rank=4"},{"key":"e_1_3_4_76_1","unstructured":"https:\/\/crinetics.com\/crinetics-paltusotine-achieved-primary-and-secondary-endpoints-in-phase-3-pathfndr-1-acromegaly-study\/accessed on 20 feb 2024"},{"key":"e_1_3_4_77_1","unstructured":"[cited 2024 feb 29]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT05192382"},{"key":"e_1_3_4_78_1","doi-asserted-by":"publisher","DOI":"10.1210\/js.2019-SAT-430"},{"key":"e_1_3_4_79_1","doi-asserted-by":"publisher","DOI":"10.1210\/js.2019-MON-459"},{"key":"e_1_3_4_80_1","doi-asserted-by":"publisher","DOI":"10.1210\/js.2019-MON-464"},{"key":"e_1_3_4_81_1","unstructured":"Available from: https:\/\/clinicaltrials.gov\/study\/NCT03571594"},{"key":"e_1_3_4_82_1","doi-asserted-by":"publisher","DOI":"10.1210\/js.2019-SAT-430"},{"key":"e_1_3_4_83_1","unstructured":"[cited 2024 feb 27]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT03849872?intr=NCT03849872&rank=1"},{"key":"e_1_3_4_84_1","doi-asserted-by":"publisher","DOI":"10.1210\/js.2019-MON-477"},{"key":"e_1_3_4_85_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.npep.2018.02.005"},{"key":"e_1_3_4_86_1","doi-asserted-by":"publisher","DOI":"10.1002\/dta.2400"},{"key":"e_1_3_4_87_1","unstructured":"[cited 2024 Feb 26]. Available from: https:\/\/www.glytech-inc.com\/pipeline\/gt-02037\/"},{"key":"e_1_3_4_88_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.12698"},{"key":"e_1_3_4_89_1","unstructured":"[cited 2024 Feb 26]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT03548415?cond=acromegaly&term=ISIS%20766720&rank=1"},{"key":"e_1_3_4_90_1","unstructured":"[cited 2024 Feb 26. Available from: https:\/\/ir.ionispharma.com\/static-files\/bbfabc7a-ccf2-44bb-a72d-6edba88a17e4"},{"key":"e_1_3_4_91_1","unstructured":"[cited 2024 Feb 26]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT04522180?cond=acromegaly&term=ISIS%20766720&rank=2"},{"key":"e_1_3_4_92_1","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvac150.1095"},{"key":"e_1_3_4_93_1","unstructured":"[cited 2024 Feb 29]. Available from: https:\/\/www.clinicaltrials.gov\/study\/NCT03967249"},{"key":"e_1_3_4_94_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-018-3734-1"},{"key":"e_1_3_4_95_1","unstructured":"[cited 2024 Feb 27. Available from: https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT04076462"},{"key":"e_1_3_4_96_1","unstructured":"[cited 2024 Feb 27]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT04125836"},{"key":"e_1_3_4_97_1","doi-asserted-by":"publisher","DOI":"10.1080\/17512433.2021.1986004"},{"key":"e_1_3_4_98_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11040955"},{"key":"e_1_3_4_99_1","unstructured":"[cited 2024 Feb 26]. Availble from: https:\/\/clinicaltrials.gov\/study\/NCT03031535?intr=dp-1038&rank=1"},{"key":"e_1_3_4_100_1","unstructured":"[cited 2024 Feb 26. Available from: https:\/\/kuleuvencongres.be\/laiconference\/documents\/bamsey-katherine-mtd201-new-generation-treatment.pdf"},{"key":"e_1_3_4_101_1","unstructured":"[cited 2024 Feb 26. Available from: https:\/\/www.biospace.com\/article\/releases\/glide-technologies-announces-successful-clinical-proof-of-concept-study-with-its-novel-octreotide-solid-dose-formulation-delivered-via-sdi-\/"},{"key":"e_1_3_4_102_1","unstructured":"[cited 2024 Feb 26]. Available from: https:\/\/www.cbinsights.com\/company\/dauntless-2"},{"key":"e_1_3_4_103_1","unstructured":"[cited 2024 Feb 27. Available from: https:\/\/www.annualreports.com\/HostedData\/AnnualReportArchive\/a\/NASDAQ_AQST_2020.pdf"},{"key":"e_1_3_4_104_1","unstructured":"[cited 2024 Feb 27]. Available from: https:\/\/adisinsight.springer.com\/trials\/700301814"},{"key":"e_1_3_4_105_1","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.1068061"},{"key":"e_1_3_4_106_1","doi-asserted-by":"publisher","DOI":"10.1097\/MED.0000000000000344"},{"key":"e_1_3_4_107_1","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa805"},{"key":"e_1_3_4_108_1","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgad174"},{"key":"e_1_3_4_109_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-2197"},{"key":"e_1_3_4_110_1","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.677919"},{"key":"e_1_3_4_111_1","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgac512"},{"key":"e_1_3_4_112_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.arcmed.2023.102924"},{"key":"e_1_3_4_113_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-2247"}],"container-title":["Expert Opinion on Investigational Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13543784.2024.2343056","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T04:43:55Z","timestamp":1718685835000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13543784.2024.2343056"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,30]]},"references-count":112,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5,3]]}},"alternative-id":["10.1080\/13543784.2024.2343056"],"URL":"https:\/\/doi.org\/10.1080\/13543784.2024.2343056","relation":{},"ISSN":["1354-3784","1744-7658"],"issn-type":[{"value":"1354-3784","type":"print"},{"value":"1744-7658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,30]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieid20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieid20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2023-12-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-04-10","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-04-30","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}